Atopic Dermatitis: Lebrikizumab for Kids

We are studying a new treatment for children and teens with moderate-to-severe atopic dermatitis. The goal is to see if it works better than a placebo when used alongside standard treatments.

3-6 months Confirmation phase (III)Post-Trial Drug Access Investigational Medicines Oral InjectionDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Cortisone

Cortisone is a steroid that reduces inflammation and suppresses the immune system to relieve swelling, pain, and allergic or autoimmune symptoms.

Lebrikizumab

Lebrikizumab is a substance that reduces skin inflammation by targeting a specific immune protein, used for moderate-to-severe eczema.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Corticosteroids

Immunosuppressants

Agents For Dermatitis

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Fakultni Nemocnice Brno

Brno, Czechia

Fakultni Nemocnice Bulovka

Dolní Chabry, Czechia

Hopitaux Drome Nord

Dermatology

Bourg-de-Péage, France

Sponsor: Eli Lilly & Co.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.